Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model

European Journal of Neuroscience

Volumn 35, Issue 1, 2012, Pages 10-19

  Kohl, Zacharias ^a   Winner, Beate ^b   Ubhi, Kiren ^c   Rockenstein, Edward ^c   Mante, Michael ^c   Münch, Martina ^a   Barlow, Carolee ^d   Carter, Todd ^d   Masliah, Eliezer ^c   Winkler, Jürgen ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BrainCells Inc   (United States)

Author keywords

Adult neurogenesis; Alpha synuclein; Antidepressants; Precursor cells; Proliferation

Indexed keywords

ALPHA SYNUCLEIN; FLUOXETINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DEVELOPMENTAL DISORDER; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ALPHA-SYNUCLEIN; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FLUOXETINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; NEUROGENESIS; PARKINSON DISEASE; PROLIFERATING CELL NUCLEAR ANTIGEN; SEROTONIN UPTAKE INHIBITORS; STEM CELLS; TRANSGENES;

EID: 84855278236     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07933.x     Document Type: Article

References (60)

1. Bowenkamp, K.E., Hoffman, A.F., Gerhardt, G.A., Henry, M.A., Biddle, P.T., Hoffer, B.J. & Granholm, A.C. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol., 355, 479-489.
2. Chen, Y., Ai, Y., Slevin, J.R., Maley, B.E. & Gash, D.M. (2005) Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp. Neurol., 196, 87-95.
3. Choi-Lundberg, D.L., Lin, Q., Chang, Y.N., Chiang, Y.L., Hay, C.M., Mohajeri, H., Davidson, B.L. & Bohn, M.C. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science, 275, 838-841.
4. Couillard-Despres, S., Wuertinger, C., Kandasamy, M., Caioni, M., Stadler, K., Aigner, R., Bogdahn, U. & Aigner, L. (2009) Ageing abolishes the effects of fluoxetine on neurogenesis. Mol. Psychiatry, 14, 856-864.
5. Crews, L., Mizuno, H., Desplats, P., Rockenstein, E., Adame, A., Patrick, C., Winner, B., Winkler, J. & Masliah, E. (2008) Alpha-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice. J. Neurosci., 28, 4250-4260.
6. Curtis, M.A., Kam, M., Nannmark, U., Anderson, M.F., Axell, M.Z., Wikkelso, C., Holtås, S., van Roon-Mom, W.M.C., Björk-Eriksson, T., Nordborg, C., Frisén, J., Dragunow, M., Faull, R.L.M. & Eriksson, P.S. (2007) Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science, 315, 1243-1249.
7. David, D.J., Samuels, B.A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., Drew, M., Craig, D.A., Guiard, B.P., Guilloux, J.-P., Artymyshyn, R.P., Gardier, A.M., Gerald, C., Antonijevic, I.A., Leonardo, E.D. & Hen, R. (2009) Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron, 62, 479-493.
8. De Foubert, G., Carney, S.L., Robinson, C.S., Destexhe, E.J., Tomlinson, R., Hicks, C.A., Murray, T.K., Gaillard, J.P., Deville, C., Xhenseval, V., Thomas, C.E., O'Neill, M.J. & Zetterstrom, T.S. (2004) Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience, 128, 597-604.
9. Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R. & Defebvre, L. (2008) Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov. Disord., 23, 850-857.
10. Dong, H., Goico, B., Martin, M., Csernansky, C.A., Bertchume, A. & Csernansky, J.G. (2004) Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience, 127, 601-609.
11. Duda, J.E., Giasson, B.I., Mabon, M.E., Miller, D.C., Golbe, L.I., Lee, V.M.-Y. & Trojanowski, J.Q. (2002) Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol., 104, 7-11.
12. Encinas, J.M., Vaahtokari, A. & Enikolopov, G. (2006) Fluoxetine targets early progenitor cells in the adult brain. Proc. Natl Acad. Sci. USA, 103, 8233-8238.
13. Eriksson, P.S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A.M., Nordborg, C., Peterson, D.A. & Gage, F.H. (1998) Neurogenesis in the adult human hippocampus. Nat. Med., 4, 1313-1317.
14. Gallagher, D.A., Lees, A.J. & Schrag, A. (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov. Disord., 25, 2493-2500.
15. Grote, H.E., Bull, N.D., Howard, M.L., van Dellen, A., Blakemore, C., Bartlett, P.F. & Hannan, A.J. (2005) Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur. J. Neurosci., 22, 2081-2088.
16. Hashimoto, M., Rockenstein, E. & Masliah, E. (2003) Transgenic models of alpha-synuclein pathology: past, present, and future. Ann. N. Y. Acad. Sci., 991, 171-188.
17. Holick, K.A., Lee, D.C., Hen, R. & Dulawa, S.C. (2008) Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology, 33, 406-417.
18. Ino, H. & Chiba, T. (2000) Expression of proliferating cell nuclear antigen (PCNA) in the adult and developing mouse nervous system. Brain Res. Mol. Brain Res., 78, 163-174.
19. Klempin, F., Babu, H., Tonelli Dde, P., Alarcon, E., Fabel, K. & Kempermann, G. (2010) Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front. Mol. Neurosci., 3, doi: 10.3389/fnmol.2010.00014.
20. Kobayashi, K., Ikeda, Y., Sakai, A., Yamasaki, N., Haneda, E., Miyakawa, T. & Suzuki, H. (2010) Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc. Natl. Acad. Sci. USA, 107, 8434-8439.
21. Kohl, Z., Regensburger, M., Aigner, R., Kandasamy, M., Winner, B., Aigner, L. & Winkler, J. (2010) Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease. BMC Neurosci., 11, 114.
22. Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.Y., Palfi, S., Roitberg, B.Z., Brown, W.D., Holden, J.E., Pyzalski, R., Taylor, M.D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. & Aebischer, P. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290, 767-773.
23. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. & Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18, 106-108.
24. Kuhn, H.G., Dickinson-Anson, H. & Gage, F.H. (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J. Neurosci., 16, 2027-2033.
25. Lang, A.E., Gill, S., Patel, N.K., Lozano, A., Nutt, J.G., Penn, R., Brooks, D.J., Hotton, G., Moro, E., Heywood, P., Brodsky, M.A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V.G., Elias, W.J., Laws, E.R., Dhawan, V., Stoessl, A.J., Matcham, J., Coffey, R.J. & Traub, M. (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol., 59, 459-466.
26. MacQueen, G.M., Campbell, S., McEwen, B.S., Macdonald, K., Amano, S., Joffe, R.T., Nahmias, C. & Young, L.T. (2003) Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. USA, 100, 1387-1392.
27. Malberg, J., Eisch, A., Nestler, E. & Duman, R. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci., 20, 9104-9110.
28. Marlatt, M.W., Lucassen, P.J. & Van Praag, H. (2010) Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Brain Res. 1341, 93-99.
29. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. & Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science, 287, 1265-1269.
30. Menza, M., Dobkin, R.D., Marin, H., Mark, M.H., Gara, M., Buyske, S., Bienfait, K. & Dicke, A. (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology, 72, 886-892.
31. Mercier, G., Lennon, A.M., Renouf, B., Dessouroux, A., Ramaugé, M., Courtin, F. & Pierre, M. (2004) MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci., 24, 207-216.
32. Miller, B.H., Schultz, L.E., Gulati, A., Cameron, M.D. & Pletcher, M.T. (2008) Genetic regulation of behavioral and neuronal responses to fluoxetine. Neuropsychopharmacology, 33, 1312-1322.
33. Miró, X., Pérez-Torres, S., Artigas, F., Puigdomènech, P., Palacios, J.M. & Mengod, G. (2002) Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology, 43, 1148-1157.
34. Mu, Y., Lee, S.W. & Gage, F.H. (2010) Signaling in adult neurogenesis. Curr. Opin. Neurobiol., 20, 416-423.
35. Nemani, V.M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M.K., Chaudhry, F.A., Nicoll, R.A. & Edwards, R.H. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron, 65, 66-79.
36. Nibuya, M., Nestler, E.J. & Duman, R.S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci., 16, 2365-2372.
37. Parent, J.M., Elliott, R.C., Pleasure, S.J., Barbaro, N.M. & Lowenstein, D.H. (2006) Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann. Neurol., 59, 81-91.
38. Peng, J. & Andersen, J.K. (2011) Mutant alpha-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. Aging Cell, 10, 255-262.
39. Politis, M., Wu, K., Loane, C., Turkheimer, F.E., Molloy, S., Brooks, D.J. & Piccini, P. (2010) Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology, 75, 1920-1927.
40. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I. & Nussbaum, R.L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
41. Ricci, V., Pomponi, M., Martinotti, G., Bentivoglio, A., Loria, G., Bernardini, S., Caltagirone, C., Bria, P. & Angelucci, F. (2010) Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. J. Clin. Psychopharmacol., 30, 751-753.
42. Sahay, A. & Hen, R. (2007) Adult hippocampal neurogenesis in depression. Nat. Neurosci., 10, 1110-1115.
43. Sahay, A., Scobie, K.N., Hill, A.S., O'Carroll, C.M., Kheirbek, M.A., Burghardt, N.S., Fenton, A.A., Dranovsky, A. & Hen, R. (2011) Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature, 472, 466-470.
44. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C. & Hen, R. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805-809.
45. Sasahara, A., Kott, J.N., Sasahara, M., Raines, E.W., Ross, R. & Westrum, L.E. (1992) Platelet-derived growth factor B-chain-like immunoreactivity in the developing and adult rat brain. Brain Res. Dev. Brain Res., 68, 41-53.
46. Scalzo, P., Kummer, A., Bretas, T.L., Cardoso, F. & Teixeira, A.L. (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J. Neurol., 257, 540-545.
47. Schulz-Schaeffer, W.J. (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol., 120, 131-143.
48. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. & Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA, 95, 6469-6473.
49. Suzuki, K., Okada, K., Wakuda, T., Shinmura, C., Kameno, Y., Iwata, K., Takahashi, T., Suda, S., Matsuzaki, H., Iwata, Y., Hashimoto, K. & Mori, N. (2010) Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine. PLoS ONE, 5, e9260.
50. Tolosa, E. & Poewe, W. (2009) Premotor Parkinson disease. Neurology, 72, S1.
51. Tomac, A., Lindqvist, E., Lin, L.F., Ogren, S.O., Young, D., Hoffer, B.J. & Olson, L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature, 373, 335-339.
52. Ueda, S., Sakakibara, S. & Yoshimoto, K. (2005) Effect of long-lasting serotonin depletion on environmental enrichment-induced neurogenesis in adult rat hippocampus and spatial learning. Neuroscience, 135, 395-402.
53. Van Praag, H., Schinder, A.F., Christie, B.R., Toni, N., Palmer, T.D. & Gage, F.H. (2002) Functional neurogenesis in the adult hippocampus. Nature, 415, 1030-1034.
54. Wang, J.W., David, D.J., Monckton, J.E., Battaglia, F. & Hen, R. (2008) Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J. Neurosci., 28, 1374-1384.
55. Williams, R.W. & Rakic, P. (1988) Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J. Comp. Neurol., 278, 344-352.
56. Winner, B., Lie, D.C., Rockenstein, E., Aigner, R., Aigner, L., Masliah, E., Kuhn, H.-G. & Winkler, J. (2004) Human wild-type alpha-synuclein impairs neurogenesis. J. Neuropathol. Exp. Neurol., 63, 1155-1166.
57. Winner, B., Rockenstein, E., Lie, D.C., Aigner, R., Mante, M., Bogdahn, U., Couillard-Despres, S., Masliah, E. & Winkler, J. (2008) Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol. Aging, 29, 913-925.
58. Winner, B., Kohl, Z. & Gage, F.H. (2011) Neurodegenerative disease and adult neurogenesis. Eur. J. Neurosci., 33, 1139-1151.
59. Yuan, Y., Sun, J., Zhao, M., Hu, J., Wang, X., Du, G. & Chen, N.H. (2010) Overexpression of alpha-synuclein down-regulates BDNF expression. Cell. Mol. Neurobiol., 30, 939-946.
60. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Munoz, D.G. & de Yebenes, J.G. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 55, 164-173.